
Background Despite the ubiquity of Theraphosidae (tarantulas) in the pet trade, the clinical literature on theraphosid envenomation is heterogeneous, geographically uneven, dominated by selective self-report, and frequently obscured by taxonomic misidentification. Methods PubMed/MEDLINE and supplementary sources were screened against pre-specified criteria for published reports of human theraphosid bites (PRISMA). Results Forty-two reports (1889–2026) entered the primary synthesis: 39 were localizable to 17 countries, one did not state the bite country, and two were international hobbyist compilations. Reporting concentrated in South Asia, in captive-keeper bites in Europe and North America, and in Australia. Among Old World species (native to Africa, Asia, and Australasia), African, South Asian, and Southeast Asian lineages were repeatedly associated with intense local pain, delayed generalized muscle cramping, creatine kinase elevation, and, rarely, transient atrial fibrillation, whereas Australian bites caused severe local pain without cramping. New World bites (species native to the Americas) predominantly produced minor local effects, with rare systemic exceptions (suspected anaphylaxis, prolonged cramping, thrombocytopenia). Only 8 of 42 reports had identification by a named arachnologist, zoologist, or institutional laboratory. No validated antivenom and no death attributable to a verified Theraphosidae bite were identified; two deaths attributed to the genus Chilobrachys in a 1997 Indian report lack documented taxonomic and causal confirmation. Conclusions Most reported theraphosid bites were minor, but the literature cannot estimate population-level risk without defined denominators. Some Old World bites were high-acuity events, and the literature has emphasized less heterogeneity in Old World envenomations than exists. Priorities include standardized species identification, prospective registries, and consistent severity reporting.
This study investigated cyanotoxin co-occurrence in interconnected water reservoirs in Southern Portugal. LC–MS/MS analysis of 69 samples confirmed the presence of microcystin-LR, microcystin-RR, cylindrospermopsin and anatoxin-a, with maximum concentrations of 1.90, 0.35, 0.69 and 0.53 μg L−1, respectively. Toxins co-occurred and showed distinct spatial profiles. This is the first report of cylindrospermopsin and anatoxin-a in the Alqueva system. Saxitoxin was detected qualitatively, and nodularin was not detected. Microcystin-LR was present at the highest measured concentration, while toxin co-occurrence reinforces the need for monitoring multiple cyanotoxins.
Snakebite envenoming disproportionately affects Indigenous populations in remote areas of the Brazilian Amazon. We compared snakebite records from Indigenous and national health information systems in Amazonas and Roraima between 2015 and 2019. Although 2150 cases were recorded in the Indigenous health database (SIASI) and 13,480 in the national system (SINAN), only 692 matched (32.2%). This low convergence suggests surveillance fragmentation, underestimation of Indigenous snakebite burden, and potential impacts on antivenom planning and equitable healthcare access.
Zearalenone (ZEA) is an estrogenic mycotoxin with documented immunotoxic effects, but its cell-type-resolved splenic responses remain incompletely characterized. In this study, C57BL/6 mice received 20 mg/kg·bw ZEA by oral gavage for 21 consecutive days. Conventional toxicological endpoints, TUNEL staining, cleaved caspase-3 immunofluorescence, and single-cell RNA sequencing (scRNA-seq) were performed using samples derived from the same exposure experiment, with two pooled libraries sequenced per group, each constructed from the spleens of five mice. Under the tested conditions, no marked changes in spleen organ coefficient or overall histopathological architecture were observed, whereas the TUNEL-positive and cleaved caspase-3-positive cell ratios were significantly increased in ZEA-exposed mice. scRNA-seq resolved 44,759 high-quality splenic cells into 15 transcriptionally distinct populations. Differential expression analysis identified cell-type-associated transcriptional changes, including altered antigen-presentation and ribosomal programs in B and T cells and changes in apoptosis-, antioxidant-, and mitochondria-related gene sets in selected populations. CellChat predicted altered intercellular communication and SCENIC inferred altered NF-κB2, STAT1, and MYC regulon activities. These findings describe increased apoptosis-related positivity accompanied by cell-type-resolved transcriptional remodeling following ZEA exposure. This exploratory atlas provides a basis for further mechanistic and dose–response studies for mycotoxin risk assessment.